SCHEMBL8549043

SCHEMBL8549043

CS(=O)(=O)c1ccccc1-c1oc(CO)nc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 17/20 0.52
RXRA P19793 7/20 0.50
RXRB P28702 5/20 0.50
NR4A1 P22736 4/20 0.50
NR4A3 Q92570 4/20 0.50
RXRG P48443 3/20 0.45
PTGS2 P35354 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ABCC4 O15439 1/20 0.45
C5 P01031 1/20 0.45
LMNA P02545 1/20 0.45
CHRM2 P08172 1/20 0.45
CYP3A4 P08684 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD2 P14416 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
TBXA2R P21731 1/20 0.45
PTGS1 P23219 1/20 0.45
HTR2A P28223 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8547182 0.90 NR4A2 (0.50) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL8547540 0.87 NR4A2 (0.49) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL9026460 0.85 NR4A2 (0.51) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL6315610 0.83 NR4A2 (0.60) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL8606455 0.82 NR4A2 (0.47) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL6309794 0.82 NR4A2 (0.47) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL6369953 0.81 NR4A2 (0.58) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL6309776 0.81 NR4A2 (0.61) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL7502033 0.81 PTGS2 (0.67) NR4A2RXRARXRBNR4A1NR4A3
SCHEMBL7502159 0.81 PTGS2 (0.67) NR4A2RXRARXRBNR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP claimed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO claimed